Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

THAM-E

POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE

Standard Dose
370MG/VIAL;1.75GM/VIAL;36GM/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview THAM-E is listed in Drugs@FDA under application 013025 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE Form and strength INJECTABLE;INJECTION - 370MG/VIAL;1.75GM/VIAL;36GM/VIAL Sponsor HOSPIRA Submission history Latest submission status date: 2013-11-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview THAM-E is listed in Drugs@FDA under application 013025 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE Form and strength INJECTABLE;INJECTION - 370MG/VIAL;1.75GM/VIAL;36GM/VIAL Sponsor HOSPIRA Submission history Latest submission status date: 2013-11-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.